Sponsor or institution

Clinical trials and research at Sichuan Cancer Hospital and Research Institute

• 11Clinical trials
• 1Country

Newest trials

All recruiting trials (11)

• Improving blood flow in sepsis patients using vitamins

  This study is testing if giving a mix of vitamins B6, B12, and C to patients with sepsis in the ICU can improve their blood flow and help them recover better.

  Recruiting Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT06749756

• Comparing neoadjuvant chemoradiotherapy and chemotherapy for advanced breast cancer

  This study tests whether combining a specific type of radiation with chemotherapy before surgery can help people with advanced breast cancer do better than just using chemotherapy alone.

  Recruiting Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT06697938

• Combining cadonilimab with chemotherapy for resectable PD-L1 negative lung cancer

  This study is testing if combining a new drug called cadonilimab with chemotherapy can help people with resectable lung cancer that has low levels of PD-L1 feel better and improve their treatment outcomes.

  Recruiting Phase 2 Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT06532591

• Combining TACE with Camrelizumab and Apatinib for Liver Cancer

  This study is testing if combining a liver cancer treatment called TACE with two drugs, camrelizumab and apatinib, can help people with advanced liver cancer live longer and feel better compared to standard treatments.

  Recruiting Phase 3 Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT06485466

• Observational study of lorlatinib for advanced ALK-positive lung cancer patients

  This study looks at how well lorlatinib works and how safe it is for people with advanced ALK-positive lung cancer who are receiving treatment.

  Recruiting Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT06361589

• MR‑guided short‑course radiation with chemotherapy and surgery for unresectable locally advanced colon cancer

  This trial will test whether MR‑Linac short‑course radiotherapy followed by chemotherapy and surgery can help people with T4 unresectable locally advanced colon cancer achieve complete tumor removal and better outcomes.

  Recruiting Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT06244537

• Assessing furmonertinib for lung cancer patients with specific mutations after surgery

  This study is testing if a new drug called furmonertinib can help lung cancer patients with specific mutations stay cancer-free after their surgery.

  Recruiting Phase 2 Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT06192849

• Preventing lung complications after gynecologic surgery using high-flow nasal oxygen

  This study is testing if high-flow nasal oxygen can help prevent lung problems after gynecologic surgery in patients who are at high risk for these issues.

  Recruiting Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT05526534

• Treatment for locally advanced nasopharyngeal carcinoma using Nituzumab

  This study is testing if adding a new drug called Nituzumab to standard chemotherapy can help people with locally advanced nasopharyngeal cancer live longer and have better treatment results.

  Recruiting Phase 2 Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT05508347

• Developing a Decision Aid for Lung Cancer Patients

  This study is trying to create a helpful tool for lung cancer patients to make better decisions about their treatment options by gathering input from patients and healthcare experts.

  Recruiting Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT05191485

• Combining chemotherapy and immunotherapy for advanced cervical cancer treatment

  This study is testing if combining chemotherapy with a new immunotherapy can help women with advanced cervical cancer live longer without their cancer getting worse.

  Recruiting Phase 3 Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT05173272

Quick answers

How many clinical trials run by Sichuan Cancer Hospital and Research Institute are recruiting right now?

11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →